UMM Institutional Repository

STUDI PENGGUNAAN PHOSPHATE BINDER PADA PASIEN CKD (CHRONIC KIDNEY DISEASE) (Penelitian dilakukan di Instalasi Rawat Inap (IRNA) RSUD Dr. Iskak Tulungagung)

Rohmah, Khoridatur (2018) STUDI PENGGUNAAN PHOSPHATE BINDER PADA PASIEN CKD (CHRONIC KIDNEY DISEASE) (Penelitian dilakukan di Instalasi Rawat Inap (IRNA) RSUD Dr. Iskak Tulungagung). Undergraduate (S1) thesis, University of Muhammadiyah Malang.

[img]
Preview
Text
PENDAHULUAN.pdf

Download (6MB) | Preview
[img]
Preview
Text
BAB I.pdf

Download (947kB) | Preview
[img]
Preview
Text
BAB II.pdf

Download (10MB) | Preview
[img]
Preview
Text
BAB III.pdf

Download (673kB) | Preview
[img]
Preview
Text
BAB IV.pdf

Download (745kB) | Preview
[img] Text
BAB V.pdf
Restricted to Registered users only

Download (1MB)
[img] Text
BAB VI.pdf
Restricted to Registered users only

Download (3MB)
[img] Text
BAB VII.pdf
Restricted to Registered users only

Download (316kB)
[img] Text
LAMPIRAN.pdf
Restricted to Registered users only

Download (3MB)

Abstract

Background: Chronic Kidney Disease (CKD) is a structural abnormality or renal function disorder that occurs for three months or more. Hyperphosphatemia is a developmental form of CKD that usually occurs in the third stage of a disease. The effect of hyperphosphatemia is a bone mineral disorder and tissue calcification. Phosphate binder is one of the therapies that can be used in overcoming hyperphosphatemia. The mechanism work is by binding the phosphate in the intestine and secreted with the feces so that the phosphate is not absorbed in the body Objective: To know the pattern of phosphate binder usage in CKD patient at hospitalization service Dr. Iskak district general hospital of Tulungagung Method: An observational retrospective. The presentation data used is descriptive data of the RMK data CKD patients hospitalized in the period Juli to December 2017. Result and Conclusion: Phosphate binder was only used singly, 130 patients (77%) used calcium carbonate, 11 patients (7%) used calcium acetate, and switched in 27 patients (16%). The most regimentation of calcium carbonate (3x500mg) PO dosage in 121 patients (62%), while on calcium acetate (1x169mg) PO as many as 16 patients (8%).

Item Type: Thesis (Undergraduate (S1))
Student ID: 201410410311202
Keywords: Phosphate Binder, calcium acetate, calcium carbonate
Subjects: R Medicine > RZ Other systems of medicine
Divisions: Faculty of Health Science > Department of Pharmacy (48201)
Depositing User: Nurhadin Nurhadin
Date Deposited: 28 Nov 2018 03:19
Last Modified: 28 Nov 2018 03:19
URI : http://eprints.umm.ac.id/id/eprint/41012

Actions (login required)

View Item View Item
UMM Official

© 2008 UMM Library. All Rights Reserved.
Jl. Raya Tlogomas No 246 Malang East Java Indonesia - Phone +62341464318 ext. 150, 151 - Fax +62341464101
E-Mail : infopus[at]umm.ac.id - Website : http://lib.umm.ac.id - Online Catalog : http://laser.umm.ac.id - Repository : http://eprints.umm.ac.id

Web Analytics

UMM Institutional Repository is powered by :
EPrints Logo